“`html
The Morgan Stanley Pathway Large Cap Equity ETF (MSLC) has an implied analyst target price of $54.89 per unit, indicating an 11.36% upside from its recent trading price of $49.29. This assessment is based on the average analyst targets for its underlying holdings.
Key underlying holdings with significant upside include Brookfield Corp (BN), trading at $57.98 with an analyst target of $68.43 (18.02% upside), Masimo Corp. (MASI), priced at $159.32 aiming for $183.71 (15.31% upside), and AbbVie Inc (ABBV), with a recent price of $185.48 and a target of $208.88 (12.62% upside).
| Name | Symbol | Recent Price | Avg. Analyst 12-Mo. Target | % Upside to Target |
|---|---|---|---|---|
| Morgan Stanley Pathway Large Cap Equity ETF | MSLC | $49.29 | $54.89 | 11.36% |
| Brookfield Corp | BN | $57.98 | $68.43 | 18.02% |
| Masimo Corp. | MASI | $159.32 | $183.71 | 15.31% |
| AbbVie Inc | ABBV | $185.48 | $208.88 | 12.62% |
“`
